I-FLOW Receives FDA Approval for New Mechanical Syringe Pump

Strategic Insights -

I-FLOW Corporation has received clearance from the U.S. Food and Drug Administration (FDA) to market a new mechanical syringe pump, which leverages the company's proprietary spring technology to deliver precise infusions of medications from standard syringes. The product is expected to be marketed in the 20-cc version starting in January 1996. The mechanical syringe pump is designed to provide low-cost, user-friendly infusion therapy, promoting patient compliance, increasing patient mobility, and saving nursing time compared to existing infusion systems.

Key Takeaways:

  • I-FLOW has received FDA approval to market a new mechanical syringe pump, which uses proprietary spring technology for precise medication infusions.
  • The product is expected to begin marketing in January 1996 in the 20-cc version.
  • The mechanical syringe pump is designed to provide low-cost, user-friendly infusion therapy, promoting greater patient compliance and mobility.
  • The product is expected to save nursing time compared to existing infusion systems, making it a popular alternative in the market.
  • I-FLOW's position as the price/performance leader in its markets will be strengthened with the introduction of this new product.
  • The mechanical syringe pump is more accurate and cost-effective than gravity-driven devices.
  • The product will be marketed to alternate sites, in addition to hospitals, due to its low cost and ease of use.
  • Donald M. Earhart, President and CEO of I-FLOW, attributes the success of the product to its unique spring technology, which enables controlled infusions from standard syringes.
  • The product is designed to deliver medications such as antibiotics, analgesics, chemotherapeutic agents, hormones, nutrients, hydration therapies, and other medical treatments.

Statistics:

  • The mechanical syringe pump is expected to reduce the cost of providing infusion therapy dramatically, making it a highly favorable alternative to existing systems.
  • The product is more accurate and cost-effective than gravity-driven devices, which are commonly used in the industry.
  • I-FLOW's mechanical syringe pump is designed to promote greater patient compliance, increase patient mobility, and save nursing time when compared to existing infusion systems.

Sources:

  • Nasdaq: IFLO
  • I-FLOW Corporation press release, dated October 23, 1995
  • U.S. Food and Drug Administration (FDA)
  • I-FLOW Corporation company profile